Back to today’s briefing

Story perspectives

Eli Lilly Sues Pharmacies Over Weight-Loss Drug Misuse

4/1/2025

28 2

Summary

Story summary

Eli Lilly is taking legal action against Strive and Empower pharmacies for allegedly illegally compounding its weight-loss drug, tirzepatide, known as Mounjaro and Zepbound. The pharmaceutical giant accuses these pharmacies of deceiving consumers with false claims of safety and personalization, steering patients away from FDA-approved options. Lawsuits have been filed in Delaware and New Jersey.

1 of 1

Story summary

Eli Lilly is taking legal action against Strive and Empower pharmacies for allegedly illegally compounding its weight-loss drug, tirzepatide, known as Mounjaro and Zepbound. The pharmaceutical giant accuses these pharmacies of deceiving consumers with false claims of safety and personalization, steering patients away from FDA-approved options. Lawsuits have been filed in Delaware and New Jersey.